Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,235 public trials 1,182 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Active, Not Recruiting

A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer

NCT03456076

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Rush University Medical Center Chicago, Illinois, United States
  • MGH Cancer Center Boston, Massachusetts, United States
  • AHN Cancer Institute ? Allegheny General Hospital Pittsburgh, Pennsylvania, United States
  • Chris O'Brien Lifehouse Camperdown, New South Wales, Australia
View all 114 locations
View Trial Details
Active, Not Recruiting

A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer

NCT05800015

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Arizona Clinical Research Center Tucson, Arizona, United States
  • Yuma Regional Medical Center Yuma, Arizona, United States
  • The Oncology Institute of Hope & Innovation Cerritos, California, United States
  • Crosson Cancer Institute Fullerton, California, United States
View all 76 locations
View Trial Details
Active, Not Recruiting

A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.

NCT02734004

Conditions
Adnexal Diseases, Breast, Breast Diseases, +34 more
Locations
  • Research Site Newnan, Georgia, United States
  • Research Site Towson, Maryland, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Detroit, Michigan, United States
View all 47 locations
View Trial Details
Active, Not Recruiting

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

NCT02864992

Conditions
Adenocarcinoma, Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Bronchial Neoplasms, +13 more
Locations
  • City of Hope Cancer Center Duarte, California, United States
  • California Cancer Associates for Research & Excellence, Inc. Encinitas, California, United States
  • St. Joseph Hospital Orange, California, United States
  • Torrance Health Association Redondo Beach, California, United States
View all 176 locations
View Trial Details
Active, Not Recruiting

Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)

NCT06577792

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Fujian Provincial Hospital Fuzhou, Fujian, China
  • Gansu Provincial Hospital Lanzhou, Gansu, China
View all 26 locations
View Trial Details
Active, Not Recruiting

A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC

NCT04995523

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations
  • Research Site Chicago, Illinois, United States
  • Research Site Rochester, Minnesota, United States
  • Research Site Fairfax, Virginia, United States
  • Research Site Melbourne, Australia
View all 40 locations
View Trial Details
Active, Not Recruiting

Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung Cancer (NSCLC) Novel Combination Study

NCT03381274

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site San Francisco, California, United States
  • Research Site Aurora, Colorado, United States
  • Research Site New Haven, Connecticut, United States
View all 13 locations
View Trial Details

Related conditions